Patents by Inventor Vanessa L. Hale

Vanessa L. Hale has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND MATERIALS FOR USING BIOMARKERS WHICH PREDICT SUSCEPTIBILITY TO CLOSTRIDIUM DIFFICILE INFECTION
    Publication number: 20240091280
    Abstract: This document relates to biomarkers of gut microbiota dysbiosis. Bacteria that are increased or decreased in gut microbiota dysbiosis can be used as biomarkers to predict dysbiosis in patients with diarrhea and/or to predict susceptibility to Clostridium difficile infection (CDI). In addition, provided herein are compositions including at least three bacteria that are decreased in gut microbiota dysbiosis which can be used, for example, to restore heathy gut microbiota (e.g., by probiotic or by fecal microbiota transplant) to treat CDI.
    Type: Application
    Filed: November 22, 2023
    Publication date: March 21, 2024
    Inventors: Purna C. Kashyap, Eric J. Battaglioli, Vanessa L. Hale
  • Methods and materials for using biomarkers which predict susceptibility to clostridium difficile infection
    Patent number: 11865146
    Abstract: This document provides biomarkers of gut microbiota dysbiosis. Bacteria that are increased or decreased in gut microbiota dysbiosis can be used as biomarkers to predict dysbiosis in patients with diarrhea and/or to predict susceptibility to Clostridium difficile infection (CDI). In addition, provided herein are compositions including at least three bacteria that are decreased in gut microbiota dysbiosis which can be used, for example, to restore heathy gut microbiota (e.g., by probiotic or by fecal microbiota transplant) to treat CDI.
    Type: Grant
    Filed: November 9, 2020
    Date of Patent: January 9, 2024
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Purna C. Kashyap, Eric J. Battaglioli, Vanessa L. Hale
  • METHODS AND MATERIALS FOR USING BIOMARKERS WHICH PREDICT SUSCEPTIBILITY TO CLOSTRIDIUM DIFFICILE INFECTION
    Publication number: 20210128644
    Abstract: This document relates to biomarkers of gut microbiota dysbiosis. Bacteria that are increased or decreased in gut microbiota dysbiosis can be used as biomarkers to predict dysbiosis in patients with diarrhea and/or to predict susceptibility to Clostridium difficile infection (CDI). In addition, provided herein are compositions including at least three bacteria that are decreased in gut microbiota dysbiosis which can be used, for example, to restore heathy gut microbiota (e.g., by probiotic or by fecal microbiota transplant) to treat CDI.
    Type: Application
    Filed: November 9, 2020
    Publication date: May 6, 2021
    Inventors: Purna C. Kashyap, Eric J. Battaglioli, Vanessa L. Hale
  • METHODS AND MATERIALS FOR USING BIOMARKERS WHICH PREDICT SUSCEPTIBILITY TO CLOSTRIDIUM DIFFICILE INFECTION
    Publication number: 20190216861
    Abstract: This document relates to biomarkers of gut microbiota dysbiosis. Bacteria that are increased or decreased in gut microbiota dysbiosis can be used as biomarkers to predict dysbiosis in patients with diarrhea and/or to predict susceptibility to Clostridium difficile infection (CDI). In addition, provided herein are compositions including at least three bacteria that are de creased in gut microbiota dysbiosis which can be used, for example, to restore heathy gut microbiota (e.g., by probiotic or by fecal microbiota transplant) to treat CDI.
    Type: Application
    Filed: September 22, 2016
    Publication date: July 18, 2019
    Applicant: Mayo Foundation for Medical Education and Research
    Inventors: Purna C. Kashyap, Eric J. Battaglioli, Vanessa L. Hale